These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24578935)

  • 21. Mutational analysis of
    Tripathi K; Goel A; Singhai A; Garg M
    World J Clin Oncol; 2020 Aug; 11(8):614-628. PubMed ID: 32879848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ras oncogene mutations in urine sediments of patients with bladder cancer.
    Buyru N; Tigli H; Ozcan F; Dalay N
    J Biochem Mol Biol; 2003 Jul; 36(4):399-402. PubMed ID: 12895299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A PCR-RFLP method for the detection of activated H-ras oncogene with a point mutation at codon 12 and 61.
    Hong SJ; Lee T; Park YS; Lee KO; Chung BH; Lee SH
    Yonsei Med J; 1996 Dec; 37(6):371-9. PubMed ID: 9048488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations of RAS gene family in specimens of bladder cancer.
    Karimianpour N; Mousavi-Shafaei P; Ziaee AA; Akbari MT; Pourmand G; Abedi A; Ahmadi A; Afshin Alavi H
    Urol J; 2008; 5(4):237-42. PubMed ID: 19101897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
    Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
    Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
    Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
    Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms in DNA repair and metabolic genes in bladder cancer.
    Sanyal S; Festa F; Sakano S; Zhang Z; Steineck G; Norming U; Wijkström H; Larsson P; Kumar R; Hemminki K
    Carcinogenesis; 2004 May; 25(5):729-34. PubMed ID: 14688016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines.
    Watanabe T; Shinohara N; Moriya K; Sazawa A; Kobayashi Y; Ogiso Y; Takiguchi M; Yasuda J; Koyanagi T; Kuzumaki N; Hashimoto A
    IUBMB Life; 2000 Apr; 49(4):317-20. PubMed ID: 10995035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk.
    Stern MC; Umbach DM; Lunn RM; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):939-43. PubMed ID: 12223443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P53 mutations in urinary bladder cancer patients from Central Poland.
    Borkowska E; Binka-Kowalska A; Constantinou M; Nawrocka A; Matych J; Kałuzewski B
    J Appl Genet; 2007; 48(2):177-83. PubMed ID: 17495352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. K-ras gene point mutations and p21ras immunostaining in human ovarian tumors.
    Semczuk A; Postawski K; Przadka D; Rozynska K; Wrobel A; Korobowicz E
    Eur J Gynaecol Oncol; 2004; 25(4):484-8. PubMed ID: 15285310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.
    Gao W; Romkes M; Zhong S; Nukui T; Persad RA; Smith PJ; Branch R; Keohavong P
    Oncol Rep; 2010 Jul; 24(1):257-62. PubMed ID: 20514470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo.
    Mann AM; Asamoto M; Chlapowski FJ; Masui T; Macatee TL; Cohen SM
    Carcinogenesis; 1992 Sep; 13(9):1651-5. PubMed ID: 1394851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
    Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
    J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.
    Xing J; Dinney CP; Shete S; Huang M; Hildebrandt MA; Chen Z; Gu J
    Cancer; 2012 Jan; 118(1):205-15. PubMed ID: 21692063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
    Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genotype study of the c-Ha-ras-1 locus in human bladder tumors.
    Bittard H; Descotes F; Billerey C; Lamy B; Adessi GR
    J Urol; 1996 Mar; 155(3):1083-8. PubMed ID: 8583569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.